These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


91 related items for PubMed ID: 10323271

  • 1. Binding of [3H]U-101958 to sigma1 receptor-like sites in human cerebellum and neuroblastoma cells.
    Helmeste DM, Shioiri T, Mitsuhashi M, Tang SW.
    Eur J Pharmacol; 1999 Apr 09; 370(2):205-9. PubMed ID: 10323271
    [Abstract] [Full Text] [Related]

  • 2. Receptor density as a factor governing the efficacy of the dopamine D4 receptor ligands, L-745,870 and U-101958 at human recombinant D4.4 receptors expressed in CHO cells.
    Gazi L, Bobirnac I, Danzeisen M, Schüpbach E, Langenegger D, Sommer B, Hoyer D, Tricklebank M, Schoeffter P.
    Br J Pharmacol; 1999 Oct 09; 128(3):613-20. PubMed ID: 10516640
    [Abstract] [Full Text] [Related]

  • 3. Neuropharmacological assessment of potential dopamine D4 receptor-selective radioligands.
    Kula NS, Tarazi FI, Baldessarini RJ, Xu L, Bakthavachalam V, Pounds S, True CD.
    Eur J Pharmacol; 1999 Feb 12; 367(1):139-42. PubMed ID: 10082277
    [Abstract] [Full Text] [Related]

  • 4. RBI-257: a highly potent dopamine D4 receptor-selective ligand.
    Kula NS, Baldessarini RJ, Kebabian JW, Bakthavachalam V, Xu L.
    Eur J Pharmacol; 1997 Jul 23; 331(2-3):333-6. PubMed ID: 9274997
    [Abstract] [Full Text] [Related]

  • 5. Substituted 4-aminopiperidines having high in vitro affinity and selectivity for the cloned human dopamine D4 receptor.
    Schlachter SK, Poel TJ, Lawson CF, Dinh DM, Lajiness ME, Romero AG, Rees SA, Duncan JN, Smith MW.
    Eur J Pharmacol; 1997 Mar 19; 322(2-3):283-6. PubMed ID: 9098699
    [Abstract] [Full Text] [Related]

  • 6. The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor.
    Gazi L, Bobirnac I, Danzeisen M, Schüpbach E, Bruinvels AT, Geisse S, Sommer B, Hoyer D, Tricklebank M, Schoeffter P.
    Br J Pharmacol; 1998 Jul 19; 124(5):889-96. PubMed ID: 9692773
    [Abstract] [Full Text] [Related]

  • 7. Multiple [3H]-nemonapride binding sites in calf brain.
    Helmeste DM, Tang SW, Li M, Fang H.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul 19; 356(1):17-21. PubMed ID: 9228185
    [Abstract] [Full Text] [Related]

  • 8. Discovery of potent dual ligands for dopamine D4 and σ1 receptors.
    Levoin N, Murthy AVR, Narendar V, Kumar NS, Aparna P, Bhavani AKD, Reddy CR, Mosset P, Grée R.
    Bioorg Med Chem; 2022 Sep 01; 69():116851. PubMed ID: 35753263
    [Abstract] [Full Text] [Related]

  • 9. II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94-1.
    Primus RJ, Thurkauf A, Xu J, Yevich E, McInerney S, Shaw K, Tallman JF, Gallagher DW.
    J Pharmacol Exp Ther; 1997 Aug 01; 282(2):1020-7. PubMed ID: 9262371
    [Abstract] [Full Text] [Related]

  • 10. An unambiguous assay for the cloned human sigma1 receptor reveals high affinity interactions with dopamine D4 receptor selective compounds and a distinct structure-affinity relationship for butyrophenones.
    Lee IT, Chen S, Schetz JA.
    Eur J Pharmacol; 2008 Jan 14; 578(2-3):123-36. PubMed ID: 17961544
    [Abstract] [Full Text] [Related]

  • 11. Binding of [3H]FH-510 to sigma ligand recognition sites in guinea-pig brain membranes.
    Tanaka M, Kaku S, Muramatsu M, Otomo S.
    Eur J Pharmacol; 1993 Jul 06; 238(1):93-100. PubMed ID: 8104804
    [Abstract] [Full Text] [Related]

  • 12. Brain sigma receptors labelled by [3H]nemonapride.
    Helmeste D, Tang SW, Fang H, Li M.
    Eur J Pharmacol; 1996 Apr 22; 301(1-3):R1-3. PubMed ID: 8773467
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological and metabolic characterisation of the potent sigma1 receptor ligand 1'-benzyl-3-methoxy-3H-spiro[[2]benzofuran-1,4'-piperidine].
    Wiese C, Grosse Maestrup E, Schepmann D, Vela JM, Holenz J, Buschmann H, Wünsch B.
    J Pharm Pharmacol; 2009 May 22; 61(5):631-40. PubMed ID: 19406002
    [Abstract] [Full Text] [Related]

  • 14. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
    Newman-Tancredi A, Audinot V, Chaput C, Verrièle L, Millan MJ.
    J Pharmacol Exp Ther; 1997 Jul 22; 282(1):181-91. PubMed ID: 9223553
    [Abstract] [Full Text] [Related]

  • 15. Decrease in sigma but no increase in striatal dopamine D4 sites in schizophrenic brains.
    Helmeste DM, Tang SW, Bunney WE, Potkin SG, Jones EG.
    Eur J Pharmacol; 1996 Oct 31; 314(3):R3-5. PubMed ID: 8957266
    [Abstract] [Full Text] [Related]

  • 16. [3H] A-369508 ([2-[4-(2-cyanophenyl)-1-piperazinyl]-N-(3-methylphenyl) acetamide): an agonist radioligand selective for the dopamine D4 receptor.
    Moreland RB, Terranova MA, Chang R, Uchic ME, Matulenko MA, Surber BW, Stewart AO, Brioni JD.
    Eur J Pharmacol; 2004 Aug 23; 497(2):147-54. PubMed ID: 15306199
    [Abstract] [Full Text] [Related]

  • 17. Differential labeling of dopamine and sigma sites by [3H]nemonapride and [3H]raclopride in postmortem human brains.
    Tang SW, Helmeste DM, Fang H, Li M, Vu R, Bunney W, Potkin S, Jones EG.
    Brain Res; 1997 Aug 08; 765(1):7-12. PubMed ID: 9310388
    [Abstract] [Full Text] [Related]

  • 18. NPC 16377, a potent and selective sigma-ligand. I. Receptor binding, neurochemical and neuroendocrine profile.
    Karbon EW, Abreu ME, Erickson RH, Kaiser C, Natalie KJ, Clissold DB, Borosky S, Bailey M, Martin LA, Pontecorvo MJ.
    J Pharmacol Exp Ther; 1993 May 08; 265(2):866-75. PubMed ID: 8388461
    [Abstract] [Full Text] [Related]

  • 19. Identification and pharmacological characterization of [125I]L-750,667, a novel radioligand for the dopamine D4 receptor.
    Patel S, Patel S, Marwood R, Emms F, Marston D, Leeson PD, Curtis NR, Kulagowski JJ, Freedman SB.
    Mol Pharmacol; 1996 Dec 08; 50(6):1658-64. PubMed ID: 8967990
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and evaluation of a 18F-labeled spirocyclic piperidine derivative as promising σ1 receptor imaging agent.
    Chen YY, Wang X, Zhang JM, Deuther-Conrad W, Zhang XJ, Huang Y, Li Y, Ye JJ, Cui MC, Steinbach J, Brust P, Liu BL, Jia HM.
    Bioorg Med Chem; 2014 Oct 01; 22(19):5270-8. PubMed ID: 25189691
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.